Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
topic_facet:"Medical Condition: Non-Small Cell Lung Cancer"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-Small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-Small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Non-Small+Cell+Lung+Cancer%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (276)
1
Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific : A Phase II, Open Label, Single-arm Study to Assess the Safety and Efficacy of AZD9291 in Asia Pacific Patients With Locally Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed With Previous Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Whose Tumours Harbour a T790M Mutation Within the Epidermal Growth Factor Receptor Gene.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017 : A Phase Ib/II Study of Anti-PD-1 Antibody Pembrolizumab and Imprime PGG for Patients With Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
3
Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged : Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearranged Non-small Cell Lung Cancer Patients With Central Nervous System (CNS) Progression After Evidence of Prior CNS Benefit on Relevant Tyrosine Kinase Inhibitors
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC : Randomized Blinded Phase III Assessment of Second or Third-Line Chemotherapy With Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced Non-Small Cell Lung Cancer and With at Least One Measurable Lung Lesion
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
A Study of BGB324(Bemcentinib) in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer : A Multi-Center Open-Label Phase I/2 Study of BGB324(Bemcentinib) in Combination With Erlotinib in Patients With Stage IIIb or Stage IV Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation : Evaluate the Efficacy and Safety of Ensartinib and Bevacizumab in Patients With Advanced, ALK-Rearranged Combined With TP53 Mutation, Non-Small Cell Lung Cancer: A Prospective, Open-label, Multi-center, Single-arm, Phase II Trial
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC) : A Single-arm Clinical Study of Anlotinib Combined With Penpulimab Plus SBRT in Metastatic Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer : Phase I Clinical Study of Tislelizumab in Combination With Bevacizumab and Pemetrexed for the First-line Treatment of Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer : Randomised Phase 2 Study of Nivolumab Versus Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
Phase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer in Patients With Mutations in the TK Domain of EGFR : Phase III, Multicenter, Open-label, Randomized Trial of Tarceva® vs Chemotherapy in Patients With Advanced NSCLC With Mutations in the TK Domain of the EGFR
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Thema: Medical Condition: Non-Small Cell Lung Cancer
Medienart
276
Aufsätze
276
E-Artikel
276
E-Ressourcen
Zeitschriftentitel
276
ClinicalTrials.gov
Thema
276
610
Carcinoma, Non-Small-Cell Lung
Medical Condition: Non-Small Cell Lung Cancer
256
Lung Neoplasms
234
Study Type: Interventional
164
Recruitment Status: Completed
105
Phase: Phase 2
44
Phase: Phase 3
42
Phase: Phase 1
40
Recruitment Status: Terminated
40
Study Type: Observational
31
Recruitment Status: Unknown status
15
Recruitment Status: Recruiting
14
Phase: Phase 1/Phase 2
13
Recruitment Status: Withdrawn
7
Recruitment Status: Not yet recruiting
6
Phase: Phase 4
4
Recruitment Status: Active, not recruiting
3
Phase: Phase 1, Phase 2
2
Adenocarcinoma
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
73
2020-
179
2010-2019
24
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
276
Englisch
Haven't found what you're looking for?
Wird geladen...